Results 31 to 40 of about 25,027 (259)

Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium

Frontiers in Endocrinology, 2021
X-linked hypophosphatemia (XLH) is the most common genetic form of hypophosphatemic rickets and osteomalacia. In this disease, mutations in the PHEX gene lead to elevated levels of the hormone fibroblast growth factor 23 (FGF23), resulting in renal ...
M. Laurent, J. De Schepper, D. Trouet, N. Godefroid, E. Boros, C. Heinrichs, B. Bravenboer, B. Velkeniers, J. Lammens, P. Harvengt, E. Cavalier, J. Kaux, J. Lombet, K. De Waele, C. Verroken, K. Van Hoeck, G. Mortier, E. Levtchenko, J. Vande Walle   +18 more
semanticscholar   +1 more source

Diagnosis, treatment-monitoring and follow-up of children and adolescents with X-linked hypophosphatemia (XLH)

Metabolism: Clinical and Experimental, 2020
Dirk Schnabel, Agnès Linglart
exaly   +2 more sources

Hypophosphatemia in Coronavirus Disease 2019 (COVID-19), Complications, and Considerations: A Systematic Review

BioMed Research International, 2022
Coronavirus disease 2019 (COVID-19) has various manifestations on different body organs, including the lungs, heart, kidneys, and central nervous system.
Mohammad Fakhrolmobasheri, Mehrbod Vakhshoori, M. Heidarpour, A. Najimi, A. Mozafari, H. Rezvanian   +5 more
semanticscholar   +1 more source

Impaired cardiac and neurological function with mild hypophosphatemia during insulin therapy for diabetic ketoacidosis and marked improvement with phosphate supplementation: A case report

Journal of Diabetes Investigation, 2021
Insulin treatment for diabetic ketoacidosis occasionally results in hypophosphatemia, which is often mild and does not require treatment. However, we experienced a case in which intravenous insulin administration resulted in myocardial injury and altered
Tomohiko Yoshida, Minoru Takemoto
doaj   +1 more source

Postoperative Hypophosphatemia as a Prognostic Factor for Postoperative Pancreatic Fistula: A Systematic Review

Medicina, 2023
Background and Objectives: Postoperative pancreatic fistula (POPF) is one of the most challenging complications after pancreatic resections, associated with prolonged hospital stay and high mortality.
Ieva Grikyte, Povilas Ignatavicius
doaj   +1 more source

Risk Factors for and Effects of Persistent and Severe Hypophosphatemia Following Ferric Carboxymaltose

Journal of Clinical Endocrinology and Metabolism, 2021
Context Hypophosphatemia, osteomalacia, and fractures are complications of certain intravenous iron formulations. Objective This study investigated risk factors for incident, severe, and persistent hypophosphatemia, and associated alterations in bone and
B. Schaefer, H. Zoller, M. Wolf
semanticscholar   +1 more source

Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome

Advances in Therapy, 2021
Some, but not all, intravenous iron formulations have been recognized to induce renal phosphate wasting syndrome. Most commonly this has been reported following treatment of iron deficiency anemia (IDA) with ferric carboxymaltose (FCM).
J. Glaspy, M. Wolf, W. Strauss
semanticscholar   +1 more source

Incidence of Hypophosphatemia after Ferric Carboxymaltose Treatment: Single Center Experience

Namık Kemal Tıp Dergisi, 2021
Aim:The aim of this study was to evaluate the incidence of hypophosphatemia after ferric carboxymaltose (FCM) infusion and the factors affecting hypophosphatemia.Materials and Methods:Ninety-two patients who received FCM treatment for iron deficiency ...
Esra TERZİ DEMİRSOY
doaj   +1 more source

Both hypophosphatemia and hyperphosphatemia are associated with increased mortality in septic patients

Frontiers in Nephrology, 2022
Objective This study was intended to explore the relationship between level of serum phosphate and prognosis in septic patients. Methods Data were obtained from the public database, which were divided into 2 subgroups according to whether they were ...
Zheng-xia Liu, Teng Li, Yi Du, Chenhu Li, W. Chong   +4 more
semanticscholar   +1 more source

Refractory Hypophosphatemia Secondary to Tumor-Induced Osteomalacia: Diagnostic Challenges and Successful Management With Burosumab. [PDF]

Cureus
Ramzan A, Lodhi FAK, Ramzan F.
europepmc   +3 more sources